Cancer Screening Using a Gene Delivery Vector
Author Information
Author(s): Browne Andrew W., Leddon Jennifer L., Currier Mark A., Williams Jon P., Frischer Jason S., Collins Margaret H., Ahn Chong H., Cripe Timothy P.
Primary Institution: Cincinnati Children's Hospital Medical Center
Hypothesis
Can a gene delivery vector induce tumors to secrete a serum biomarker for cancer screening?
Conclusion
The study demonstrated that a gene delivery vector can effectively induce tumors to secrete a biomarker, allowing for cancer detection.
Supporting Evidence
- The gene delivery vector induced higher biomarker levels in tumor-bearing mice compared to tumor-free mice.
- Virus replication was low in normal cells but high in cancer cells.
- The approach could potentially be used for cancer screening in high-risk patients.
Takeaway
Researchers found a way to make tumors release a special marker that can be detected in the blood, helping to find cancer early.
Methodology
The study involved injecting a modified herpes virus into tumor-bearing mice to induce biomarker secretion and measuring the levels in the blood.
Potential Biases
Potential immune responses to the gene delivery vector could affect the results.
Limitations
The study was conducted in mice, and the scalability to humans is uncertain.
Participant Demographics
Mice with various tumor types were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website